Ren Z - Search Results

1

Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance.

Liang Y, Tang H, Guo J, Qiu X, Yang Z, Ren Z, Sun Z, Bian Y, Xu L, Xu H, Shen J, Han Y, Dong H, Peng H, Fu YX. Liang Y, et al. Among authors: ren z. Nat Commun. 2018 Nov 2;9(1):4586. doi: 10.1038/s41467-018-06890-y. Nat Commun. 2018. PMID: 30389912 Free PMC article.

2

PD-1 Shapes B Cells as Evildoers in the Tumor Microenvironment.

Ren Z, Peng H, Fu YX. Ren Z, et al. Cancer Discov. 2016 May;6(5):477-8. doi: 10.1158/2159-8290.CD-16-0307. Cancer Discov. 2016. PMID: 27138562 Free PMC article.

3

CTLA-4 Limits Anti-CD20-Mediated Tumor Regression.

Ren Z, Guo J, Liao J, Luan Y, Liu Z, Sun Z, Liu X, Liang Y, Peng H, Fu YX. Ren Z, et al. Clin Cancer Res. 2017 Jan 1;23(1):193-203. doi: 10.1158/1078-0432.CCR-16-0040. Epub 2016 Jun 27. Clin Cancer Res. 2017. PMID: 27354469 Free PMC article.

4

Converting Lymphoma Cells into Potent Antigen-Presenting Cells for Interferon-Induced Tumor Regression.

Liao J, Luan Y, Ren Z, Liu X, Xue D, Xu H, Sun Z, Yang K, Peng H, Fu YX. Liao J, et al. Among authors: ren z. Cancer Immunol Res. 2017 Jul;5(7):560-570. doi: 10.1158/2326-6066.CIR-16-0221. Epub 2017 May 22. Cancer Immunol Res. 2017. PMID: 28533311 Free PMC article.

5

Dual Targeting of Innate and Adaptive Checkpoints on Tumor Cells Limits Immune Evasion.

Liu X, Liu L, Ren Z, Yang K, Xu H, Luan Y, Fu K, Guo J, Peng H, Zhu M, Fu YX. Liu X, et al. Among authors: ren z. Cell Rep. 2018 Aug 21;24(8):2101-2111. doi: 10.1016/j.celrep.2018.07.062. Cell Rep. 2018. PMID: 30134171 Free article.

6

Targeting Tumors with IL-10 Prevents Dendritic Cell-Mediated CD8⁺ T Cell Apoptosis.

Qiao J, Liu Z, Dong C, Luan Y, Zhang A, Moore C, Fu K, Peng J, Wang Y, Ren Z, Han C, Xu T, Fu YX. Qiao J, et al. Among authors: ren z. Cancer Cell. 2019 Jun 10;35(6):901-915.e4. doi: 10.1016/j.ccell.2019.05.005. Cancer Cell. 2019. PMID: 31185213 Free article.

7

Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunity.

Liu Z, Han C, Dong C, Shen A, Hsu E, Ren Z, Lu C, Liu L, Zhang A, Timmerman C, Pu Y, Wang Y, Chen M, Qiao J, Fu YX. Liu Z, et al. Among authors: ren z. Sci Immunol. 2019 Aug 9;4(38):eaav6473. doi: 10.1126/sciimmunol.aav6473. Sci Immunol. 2019. PMID: 31399492

8

A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8⁺ T-cell response and effective tumor control.

Sun Z, Ren Z, Yang K, Liu Z, Cao S, Deng S, Xu L, Liang Y, Guo J, Bian Y, Xu H, Shi J, Wang F, Fu YX, Peng H. Sun Z, et al. Among authors: ren z. Nat Commun. 2019 Aug 28;10(1):3874. doi: 10.1038/s41467-019-11782-w. Nat Commun. 2019. PMID: 31462678 Free PMC article.

9

Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling.

Han C, Liu Z, Zhang Y, Shen A, Dong C, Zhang A, Moore C, Ren Z, Lu C, Cao X, Zhang CL, Qiao J, Fu YX. Han C, et al. Among authors: ren z. Nat Immunol. 2020 May;21(5):546-554. doi: 10.1038/s41590-020-0641-5. Epub 2020 Mar 30. Nat Immunol. 2020. PMID: 32231300

10

Author Correction: A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8⁺ T-cell response and effective tumor control.

Sun Z, Ren Z, Yang K, Liu Z, Cao S, Deng S, Xu L, Liang Y, Guo J, Bian Y, Xu H, Shi J, Wang F, Fu YX, Peng H. Sun Z, et al. Among authors: ren z. Nat Commun. 2020 Apr 1;11(1):1716. doi: 10.1038/s41467-020-15532-1. Nat Commun. 2020. PMID: 32238807 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,475 results

Search Page

Filters